Rocket Pharmaceuticals, Inc. (RCKT)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
Oct 21, 16:00
2.195
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Net Income (Annual) : -223.12M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -223.12M |
| December 31, 2024 | -258.75M |
| December 31, 2023 | -245.60M |
| December 31, 2022 | -221.86M |
| December 31, 2021 | -169.07M |
| December 31, 2020 | -139.70M |
| December 31, 2019 | -77.27M |
| Date | Value |
|---|---|
| December 31, 2018 | -74.52M |
| December 31, 2017 | -19.58M |
| December 31, 2016 | -42.85M |
| December 31, 2015 | -67.98M |
| December 31, 2014 | -9.531M |
| December 31, 2013 | -7.616M |
| December 31, 2012 | -6.058M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | -713.41M |
| Intellia Therapeutics, Inc. | -412.69M |
| Beam Therapeutics, Inc. | -79.99M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |